The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
The Effect of Type 2 Diabetes Mellitus on the Presentation and Treatment Response of Pulmonary Tuberculosis
Open accessAbstract
BACKGROUND: Diabetes mellitus (DM) is a known risk factor for tuberculosis (TB), and with the increasing prevalence of type 2 DM in less developed regions, many patients with TB will have concomitant DM. Presently, little is known about the effect of DM on the clinical presentation and treatment outcome of TB. METHODS: In an urban setting in Indonesia, 737 patients with pulmonary TB were screened for DM and were followed up prospectively during TB treatment. Clinical characteristics and outcome were compared between patients with TB who had DM and patients with TB who did not have DM. RESULTS: DM was diagnosed in 14.8% of patients with TB and was associated with older age and a greater body weight. On presentation, diabetic patients with TB had more symptoms but had no evidence of more-severe TB. After 2 months, results of sputum microscopic examination was more often positive in diabetic patients (18.1% vs. 10.0%). After 6 months, 22.2% of cultured sputum specimens from diabetic patients were positive for Mycobacterium tuberculosis (adjusted odds ratio, 7.65; P=.004). CONCLUSION: DM seems to have a negative effect on the outcome of TB treatment. The underlying mechanisms for the different response to treatment in diabetic patients with TB must be explored. Screening for DM and subsequent glycemic control may improve the outcome of TB treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Mor, V., Laliberte, L., Morris, J. N., & Wiemann, M. (1984) · Cancer · doi:10.1002/1097-0142(19840501)53:9<2002::aid-cncr2820530933>3.0.co;2-w · Cited by 1,067
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/diacare.29.s1.06.s43 · Cited by 924
Therapeutic Drug Monitoring in the Treatment of Tuberculosis
Peloquin, C. A. (2002) · Drugs · doi:10.2165/00003495-200262150-00001 · Cited by 446
Pharmacokinetics-Pharmacodynamics of Rifampin in an Aerosol Infection Model of Tuberculosis
Jayaram, R., Gaonkar, S., Kaur, P., Suresh, B. L., Mahesh, B. N., Jayashree, R., Nandi, V., Bharat, S., Shandil, R. K., Kantharaj, E., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2118-2124.2003 · Cited by 335
Tuberculosis and Diabetes in Southern Mexico
Ponce-de-Leon, A., Garcia-Garcia, M. D. L., Garcia-Sancho, M. C., Gomez-Perez, F. J., Valdespino-Gomez, J. L., Olaiz-Fernandez, G., Rojas, R., Ferreyra-Reyes, L., Cano-Arellano, B., Bobadilla, M., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1584 · Cited by 239
Jindani, A., Nunn, A., & Enarson, D. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17141-9 · Cited by 238
Shetty, N., Shemko, M., Vaz, M., & D′Souza, G. (2006) · PubMed · Cited by 192
Incidence of pulmonary tuberculosis among diabetics
Kim, S. J., Hong, Y. P., Lew, W. J., Yang, S. C., & Lee, E. G. (1995) · Tubercle and Lung Disease · doi:10.1016/0962-8479(95)90529-4 · Cited by 181
Diabetes mellitus is strongly associated with tuberculosis in Indonesia.
Alisjahbana, B., van Crevel, R., Sahiratmadja, E., den Heijer, M., Maya, A., Istriana, E., Danusantoso, H., Ottenhoff, T. H. M., Nelwan, R. H. H., & van der Meer, J. W. M. (2006) · PubMed · Cited by 179
Self-citationRisk factors for pulmonary tuberculosis in Russia: case-control study
Coker, R., McKee, M., Atun, R., Dimitrova, B., Dodonova, E., Kuznetsov, S., & Drobniewski, F. (2006) · BMJ · doi:10.1136/bmj.38684.687940.80 · Cited by 179
Type 2 diabetes and tuberculosis in a dynamic bi-national border population
RESTREPO, B. I., FISHER-HOCH, S. P., CRESPO, J. G., WHITNEY, E., PEREZ, A., SMITH, B., & McCORMICK, J. B. (2007) · Epidemiology and Infection · doi:10.1017/s0950268806006935 · Cited by 160
Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania
Mugusi, F. M., Swai, A. B. M., Alberti, K. G. M. M., & McLarty, D. G. (1990) · Tubercle · doi:10.1016/0041-3879(90)90040-f · Cited by 121
The Association of Diabetes and Tuberculosis
Root, H. F. (1934) · New England Journal of Medicine · doi:10.1056/nejm193401042100101 · Cited by 114
Klingeren, B. V., Dessens-Kroon, M., van der Laan, T., Kremer, K., & van Soolingen, D. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00244-07 · Cited by 105
Boucot, K. R., Dillon, E. S., COOPER, D. A., MEIER, P., & RICHARDSON, R. (1951) · PubMed · doi:10.1164/art.1952.65.1.1 · Cited by 95
Does diabetes alter the radiological presentation of pulmonary tuberculosis
Shaikh, M. A., Singla, R., Khan, N. B., et al. (2003) · Saudi Medical Journal · doi:10.15537/1658-3175.1992 · Cited by 58
Cited by
Tuberculosis and diabetes mellitus: convergence of two epidemics
Dooley, K. E., & Chaisson, R. E. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70282-8 · Cited by 932
The impact of diabetes on tuberculosis treatment outcomes: A systematic review
Baker, M. A., Harries, A. D., Jeon, C. Y., Hart, J. E., Kapur, A., Lönnroth, K., Ottmani, S.-E., Goonesekera, S. D., & Murray, M. B. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-81 · Cited by 881
Narasimhan, P., Wood, J., MacIntyre, C. R., & Mathai, D. (2013) · Pulmonary Medicine · doi:10.1155/2013/828939 · Cited by 731
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
Alsultan, A., & Peloquin, C. A. (2014) · Drugs · doi:10.1007/s40265-014-0222-8 · Cited by 444
Hodgson, K., Morris, J., Bridson, T., Govan, B., Rush, C., & Ketheesan, N. (2015) · Immunology · doi:10.1111/imm.12394 · Cited by 367
Metadata
- Authors
- Alisjahbana, B., Sahiratmadja, E., Nelwan, E. J., Purwa, A. M., Ahmad, Y., Ottenhoff, T. H. M., Nelwan, R. H. H., Parwati, I., Meer, J. W. M. V. D., & Crevel, R. V.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-08-15
- Volume
- 45
- Issue
- 4
- Pages
- 428-435
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2037218197
- Cited by
- 374
- References
- 17
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.